Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Fatigue? 6,819 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6,819 reports of Fatigue have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 17.4% of all adverse event reports for CABOZANTINIB S-MALATE.

6,819
Reports of Fatigue with CABOZANTINIB S-MALATE
17.4%
of all CABOZANTINIB S-MALATE reports
261
Deaths
897
Hospitalizations

How Dangerous Is Fatigue From CABOZANTINIB S-MALATE?

Of the 6,819 reports, 261 (3.8%) resulted in death, 897 (13.2%) required hospitalization, and 27 (0.4%) were considered life-threatening.

Is Fatigue Listed in the Official Label?

Yes, Fatigue is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560) Death (2,504)

What Other Drugs Cause Fatigue?

ADALIMUMAB (29,420) LENALIDOMIDE (22,956) ETANERCEPT (19,907) METHOTREXATE (19,885) RITUXIMAB (15,602) PALBOCICLIB (15,190) PREDNISONE (14,320) TOCILIZUMAB (13,802) TOFACITINIB (13,551) INFLIXIMAB (13,473)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Fatigue Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Fatigue Reports All Drugs Causing Fatigue CABOZANTINIB S-MALATE Demographics